| Literature DB >> 20209058 |
Kristin L Nichol1, Kate Tummers, Alanna Hoyer-Leitzel, Jennifer Marsh, Matt Moynihan, Steven McKelvey.
Abstract
BACKGROUND: College and university students experience substantial morbidity from influenza and influenza-like illness, and they can benefit substantially from vaccination. Public health authorities encourage vaccination not only before the influenza season but also into and even throughout the influenza season. We conducted the present study to assess the impact of various vaccination strategies including delayed (i.e., in-season) vaccination on influenza outbreaks on a college campus. METHODS/Entities:
Mesh:
Substances:
Year: 2010 PMID: 20209058 PMCID: PMC2832017 DOI: 10.1371/journal.pone.0009548
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Structure of SIR model.
Shown are the various population compartments as people move through the Susceptible → Infected → Recovered states. Yellow denotes susceptible, green infected and blue recovered.
Key infection parameter values.*
| Infectious period, days (1/γ) | Infectious contact rate (No. infected contacts per day of infectiousness) (β) | |
| Unvaccinated students | ||
| Symptomatic illness | 5 | 0.5 |
| Asymptomatic infection | 1.9 | 0.25 |
| Unvaccinated faculty | ||
| Symptomatic illness | 5 | 0.3 |
| Asymptomatic infection | 1.9 | 0.15 |
| Vaccinated students | ||
| Symptomatic illness | 4 | 0.5 |
| Asymptomatic infection | 1 | 0.25 |
| Vaccinated faculty | ||
| Symptomatic illness | 4 | 0.3 |
| Asymptomatic infection | 1 | 0.15 |
*For the models we assumed that vaccine efficacy was 80% for preventing illness, that 65% of infected persons were symptomatic, that asymptomatic persons would be about half as infectious as symptomatic persons with a shorter infectious period, and that faculty would be less infectious than students. We also assumed that the infectious period duration would be reduced among vaccine failures. See the methods section for additional details and references supporting these assumptions for the models' parameter values.
Figure 2Impact of different pre-season vaccination rates on seasonal influenza outbreak curves.
In these scenarios all vaccine was administered pre-season.
Impact of varying pre-season, delayed, and total vaccination rates on influenza outbreaks.*
| Total % Vacc | Pre- Season Vacc, % | Delayed Vacc, % | In-Season Delay (days) | Total Attack Rate, % | Peak Day of Outbreak | Outbreak Duration (days) |
| 0% | 0% | 0% | 0 | 69% | 47 | 116 |
| 20% | 20% | 0% | 0 | 45% | 68 | 157 |
| 10% | 10% | 30 | 46% | 57 | 144 | |
| 42 | 47% | 52 | 135 | |||
| 0% | 20% | 30 | 47% | 45 | 128 | |
| 42 | 52% | 40 | 110 | |||
| 40% | 40% | 0% | 0 | 13% | 137 | >200 |
| 20% | 20% | 30 | 18% | 65 | >200 | |
| 42 | 21% | 49 | 167 | |||
| 30% | 10% | 30 | 16% | 99 | >200 | |
| 42 | 17% | 85 | >200 | |||
| 10% | 30% | 30 | 21% | 42 | 160 | |
| 42 | 29% | 40 | 122 | |||
| 0% | 40% | 30 | 26% | 25 | 124 | |
| 42 | 40% | 39 | 94 | |||
| 60% | 60% | 0% | 0 | <1% | 29 | 21 |
| 30% | 30% | 30 | 2% | 27 | 77 | |
| 42 | 4% | 39 | 98 | |||
| 40% | 20% | 30 | 1% | 27 | 57 | |
| 42 | 1% | 39 | 75 | |||
| 50% | 10% | 30 | <1%% | 27 | 32 | |
| 42 | <1% | 39 | 43 | |||
| 20% | 40% | 30 | 5% | 28 | 103 | |
| 42 | 10% | 40 | 110 | |||
| 10% | 50% | 30 | 8% | 27 | 109 | |
| 42 | 19% | 39 | 92 | |||
| 0% | 60% | 30 | 14% | 27 | 87 | |
| 42 | 34% | 39 | 79 |
*Vacc denotes vaccination. Delayed vaccination occurred after the onset of the outbreak Total vaccination rates = pre-season + delayed. Outbreak duration was defined as the time from the initial infectious contact to the time when there was <1 infectious person in the population.
Figure 3Influenza outbreak curves with varying pre-season and delayed vaccination rates.
For all scenarios the total vaccination rate was 40%. Shown are examples with delayed (ie in-season) vaccination occurring 30 days (3a) or 42 days (3b) after the onset of the outbreak. Pre-season vaccination rates = 40% minus delayed vaccination rate.
Figure 4Impact of adding delayed (i.e., in-season) vaccination to pre-season vaccination on total attack rates during influenza outbreaks.
Shown are total attack rates for varying levels of pre-season vaccination and delayed (ie in-season) vaccination. In-season vaccination was assumed to occur either 30 or 42 delays after the onset of the outbreak. Total vaccination rates can be calculated by taking the sum of the indicated pre-season rate and delayed vaccination rate.
Sensitivity analyses exploring the impact of changing selected parameter values on the model results.*
| Peak Day | Total Attack Rate, % | Outbreak Duration (days) | |
|
| |||
| 0% | 47 | 69% | 116 |
| 20% (base case) | 68 | 45% | 157 |
| 40% | 137 | 13% | >200 |
| 60% | – | <1% | – |
|
| |||
| Base case (both at 20%) | 68 | 45% | 157 |
| Faculty 30%, student 20% | 70 | 44% | 159 |
| Faculty 40%, student 20% | 71 | 43% | 162 |
|
| |||
| 1 symptomatic student (base case) | 68 | 45% | 157 |
| 10 symptomatic students | 41 | 46% | 128 |
| 20 symptomatic students | 33 | 47% | 117 |
| 1 symptomatic faculty | 74 | 45% | 163 |
|
| |||
| Base case | 68 | 45% | 157 |
| +10% from base case | 55 | 54% | 143 |
| +25% from base case | 42 | 63% | 107 |
| −10% from base case | 92 | 34% | >200 |
| −25% from base case | 187 | 5% | >200 |
|
| |||
| Base case (asymptomatic = 0.5x symptomatic) | 68 | 45% | 157 |
| −10% for symptomatic, no change asymptomatic | 89 | 35% | 196 |
| −25% for symptomatic, no change for asymptomatic | 160 | 14% | >200 |
|
| |||
| Base case | 68 | 45% | 157 |
| +10% from base case | 60 | 54% | 143 |
| +25% from base case | 53 | 63% | 133 |
| −10% from base case | 83 | 34% | 182 |
| −25% from base case | 140 | 7% | >20 |
|
| |||
| Base case (infectious period reduced by about 1 day, infectious contact rates same as for unvaccinated persons among vaccine failures) | 68 | 45% | 157 |
| Infectious contact rates & infectious periods reduced by 50% among vaccine failures | 73 | 42% | 148 |
*See table 1 for base case parameter values.
**National data suggest that adults >25 years of age tend to have higher vaccination rates than persons 18 to 25 years of age.[see Centers for Disease Control and Prevention, Behavioral Risk Factor Surveillance System data for influenza vaccination for 2005: http://www.cdc.gov/brfss].
***These scenarios were constructed to explore the impact of withdrawal of symptomatic persons with resulting decreases in infectious contact rates on TARs.